Download Files:
Fluphenazine-d8 (dihydrochloride)
SKU
HY-A0081S-1 mg
Category Isotope-Labeled Compounds
Tags Dopamine Receptor, GPCR/G Protein;Neuronal Signaling, Neurological Disease; Cancer
$450 – $2,400
Products Details
Product Description
– Fluphenazine-d8 (dihydrochloride) is the deuterium labeled Fluphenazine dihydrochloride. Fluphenazine dihydrochloride is a phenothiazine-class D1DR and D2DR inhibitor; used to deliver Fluphenazine to biological systems in studies probing the effects and metabolic fates of this commonly used dopamine antagonist.
Web ID
– HY-A0081S
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Molecular Formula
– C22H20D8Cl2F3N3OS
References
– [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |[2]Trzeciak HI, et al. Behavioral effects of withdrawal of fluphenazine after long-term treatment. Arzneimittelforschung. 1976;26(9):1697-700.|[3]Whelpton R, Curry SH. Effect of 20, 6Methods for study of fluphenazine kinetics in man. J Pharm Pharmacol. 1976 Dec;28(12):869-73.|[4]Javaid JI, et al. Fluphenazine determination in human plasma by a sensitive gas chromatographic method using nitrogen detector. J Chromatogr Sci. 1981 Sep;19(9):439-43.
Molecular Weight
– 518.49
Compound Purity
– 99.81
SMILES
– FC(C1=CC=C2SC3=C(C=CC=C3)N(C2=C1)CCCN4C([2H])(C([2H])(N(CCO)C([2H])(C4([2H])[2H])[2H])[2H])[2H])(F)F.[2HCl]
Clinical Information
– No Development Reported
Research Area
– Neurological Disease; Cancer
Solubility
– 10 mM in DMSO
Target
– Dopamine Receptor
Pathway
– GPCR/G Protein;Neuronal Signaling
Product type
– Isotope-Labeled Compounds
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.